Citigroup’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $866K | Sell |
|
|||||
|
2025
Q2 | $1.63M | Sell |
|
|||||
|
2025
Q1 | $5.03M | Buy |
|
|||||
|
2024
Q4 | $6.17M | Buy |
|
|||||
|
2024
Q3 | $3.31M | Buy |
|
|||||
|
2024
Q2 | $1.39M | Sell |
|
|||||
|
2024
Q1 | $11.6M | Buy |
|
|||||
|
2023
Q4 | $3.64M | Buy |
|
|||||
|
2023
Q3 | $2.49M | Buy |
|
|||||
|
2023
Q2 | $998K | Sell |
|
|||||
|
2023
Q1 | $1.67M | Buy |
|
|||||
|
2022
Q4 | $894K | Sell |
|
|||||
|
2022
Q3 | $1.38M | Buy |
|
|||||
|
2022
Q2 | $932K | Buy |
|
|||||
|
2022
Q1 | $340K | Sell |
|
|||||
|
2021
Q4 | $1.48M | Buy |
|
|||||
|
2021
Q3 | $500K | Buy |
|
|||||
|
2021
Q2 | $87K | Buy |
|
|||||
|
2021
Q1 | $43K | Sell |
|
|||||
|
2020
Q4 | $145K | Buy |
|
|||||
|
2020
Q3 | $78K | Sell |
|
|||||
|
2020
Q2 | $115K | Buy |
|
|||||
|
2020
Q1 | $47K | Buy |
|
|||||
|
2019
Q4 | $56K | Buy |
|
|||||
|
2019
Q3 | $18K | Sell |
|
|||||
|
2019
Q2 | $92K | Buy |
|
|||||
|
2019
Q1 | $61K | Buy |
|
|||||
|
2018
Q4 | $45K | Sell |
|
|||||
|
2018
Q3 | $56K | Buy |
|